Stocks to watch: Great Eastern, Seatrium, SingLand, Raffles Medical, Hong Leong Finance
Srinidhi Ragavendran
DeeperDive is a beta AI feature. Refer to full articles for the facts.
THE following companies saw new developments that may affect trading of their securities on Monday (Feb 26): Great Eastern : The insurance arm of OCBC reported on Monday a 13 per cent fall in H2 profit of S$337.4 million on the year. Earnings per share for the period stood at S$0.71, down 13 per cent from S$0.82 in the year-ago period. The board proposed a final dividend of S$0.40, which will be payable on May 17 upon shareholders’ approval at the annual general meeting. The counter closed Friday down 0.3 per cent or S$0.05 to S$18.24. Seatrium : The group on Monday reported a wider second-half net loss of S$1.7 billion compared to a net loss of S$118.3 million in the same period last year. It also proposed a 20-to-1 share consolidation exercise. Separately, the group announced it reached in-principle settlement agreements with Brazilian authorities to pay 670.7 million reais (S$182.4 million), with a further provision of S$82.4 million for indemnity to Keppel Corporation, in relation to Operation Car Wash. Shares of Seatrium ended Friday down S$0.007 or 7 per cent at S$0.093.
Singapore Land Group (SingLand): The real estate company reported a 7 per cent rise in net profit to S$102.4 million in the six months ended Dec 31, 2023, from S$95.3 million in the same period a year earlier. On Friday, the company said that this was mainly due to fair-value gain on subsidiaries’ investment properties of S$14.5 million in the half year, compared with a S$6.6 million fair-value loss recorded in H2 FY2022. SingLand shares closed up 0.6 per cent or S$0.01 to S$1.82, before the announcement.
Raffles Medical Group : The medical services provider on Monday posted a 63.8 per cent drop in net profit to S$30.3 million for the second half ended Dec 31, 2023, from S$83.7 million in the previous corresponding period. The weaker performance came as Covid-19-related activities were discontinued in FY2023, the group said in a press statement. Shares of mainboard-listed Raffles Medical closed 1 per cent or S$0.01 higher at S$1.05 on Friday.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025